Sorrento Therapeutics Announces Discovery of a Potential Non-Dopaminergic Approach to Controlling Parkinson’s Motor Symptoms
Seelos Therapeutics Announces Acquisition of an Exclusive License to Intellectual Property from The UC Regents
medical-device-investing PathMaker Neurosystems Announces Publication of Scientific Paper Establishing First Linkage Between Spasticity and Overexpression of a Specific Neuronal Cotransporter
pharmaceutical-investing Adamas Announces Publication of Data Demonstrating Dyskinesia’s Impact on Activities of Daily Living in People with Parkinson’s Disease
International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson’s Disease
pharmaceutical-investing Cynapsus Therapeutics Up 115% on US$624 million Acquisition by Sunovion Pharmaceuticals
